Trial Profile
A Comparative study of sildenafil and doxazosin controlled-release gastrointestinal therapeutic system (GITS) versus sildenafil in Chinese patients with erectile dysfuction and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Doxazosin (Primary) ; Sildenafil (Primary)
- Indications Benign prostatic hyperplasia; Erectile dysfunction; Lower urinary tract symptoms
- Focus Therapeutic Use
- 22 Dec 2011 New trial record